Follow-up of Covid-19 Long Term Sequelae
Key facts
- Who runs it
- Azienda Ospedaliera Universitaria Integrata Verona
- Where
- Belgium, Congo - Brazzaville, France, Italy, Netherlands, and Spain7 sites in 6 countriesChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 7,599 people enrolled
- Started
- 16 Apr 2021
- Ended
- 31 May 2024
- Type of study
- Observational
- Treatments tested
- Not applicable (observational study)
- Record updated
- 28 October 2024
Who can take part
- Age
- 14 years and older
- Sex
- Women and men
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Any comorbidity
- Laboratory confirmed SARS-CoV-2 infection by PCR diagnosis from nasopharynx, oropharynx, bronchoalveolar lavage, stool, or blood. Rapid tests are an acceptable alternative
- Individuals (or attorney or deputy who has been authorized to make the decision for patients who lack capacity) consent to participate
- Individuals over 14 years of ages
Who cannot take part
- Lack of laboratory confirmed SARS-CoV-2 infection
- Individuals under 14 years of ages
- Lack of consent to participate
Where is this trial?
It has sites in 6 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
The protocol, in accordance with the objectives of ORCHESTRA project - Work Package 2, aims at investigating the characteristics and determinants of COVID-19 long-term sequelae. This goal will be reached through the harmonization of follow-up strategies across the participating cohorts to allow a standardized collection of data on COVID-19 long-term sequelae. The result will be a platform including a set of data and biomaterials from large scale international cohorts, that will be uniformly recorded, prospectively tracked and analysed. The ultimate goal will be that of providing evidence to contribute to the optimization and improvement of the management and prevention of COVID-19 sequelae.
Read full original descriptionShow less
The follow-up will be organized in multiple levels of tests, according to the capability of each cohort, and will include questionnaires to collect demographic, epidemiological and clinical data, physical examination, radiological exams and biological sampling. The long-term follow-up will also allow the assessment of long-term immunological response to SARS-CoV-2 infection and its association to the vaccination and to different treatment strategies, including monoclonal antibodies.
Treatments tested
- Not applicable (observational study)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- ORCHESTRA WP2 - Follow-up of Covid-19 Long Term Sequelae
- Publications
- Record updated
- 28 October 2024